Ethical and Statistical Issues in the Randomized Controlled Trial Assessing Cost-Effectiveness of Olanzapine Versus Aprepitant

Abstract

 

I recently read the economic evaluation of olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting by Badarudin et al with great interest. I would like to highlight several ethical and methodological concerns regarding their study.

Authors

Manraj Singh Sra

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×